A $96 million RNA pilot manufacturing facility aimed at bridging the gap between research and commercialisation in New South Wales will be established at Macquarie University after the state government secured Myeloid Therapeutics as the sole operator. The facility, which will be located on the university’s Wallumattagal campus, is expected to boost the state’s mRNA…

The post Macquarie Uni to host NSW’s $96m RNA vaccine facility appeared first on InnovationAus.com.

This post was originally published on InnovationAus.com.